Drugs / SCBaL/M9
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00062530 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCBaL/M9 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00062530 ↗ |
| Modality | Vaccine | “oral HIV vaccine” NCT00062530 ↗ |
| Route | Oral | “delivered orally by live attenuated Salmonella typhi” NCT00062530 ↗ |